Nu Skin gets “nu” chief exec
This article was originally published in The Tan Sheet
Exec VP-General Counsel Truman Hunt promoted to president and CEO; he assumes role of president immediately and will become CEO at May annual meeting. Hunt has been at Nu Skin for six years, during which time he managed company's initial public offering, worked as chief legal officer and was a member of the Executive Management Committee. Prior to working at Nu Skin, he served as president of Better Living Products, a Nu Skin affiliate. Hunt replaces President & CEO Steven Lund, who accepted an assignment in the Church of Jesus Christ of Latter-Day Saints missionary program. Hunt's position will be filled by Matthew Dorny, formerly assistant general counsel...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”